<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">TRICHLORMETHIAZIDE</span><br/>(trye-klor-meth-eye'a-zide)<br/><b>Classifications:</b> <span class="classification">fluid and water balance agent</span>; <span class="classification">thiazide diuretic</span>; <span class="classification">antihypertensive</span><br/><b>Prototype: </b>Hydrochlorothiazide<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>4 mg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Benzothiadiazine (thiazide) derivative. Similar to hydrochlorothiazide. Diuretic effect associated with drug interference
         with transport of sodium ions across renal tubular epithelium, which enhances excretion of sodium, chloride, potassium, bicarbonate,
         and water. Site of drug action is the cortical dilution segment of the nephron.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Loss of fluid and sodium results in antihypertensive effect.</p>
<h1><a name="uses">Uses</a></h1>
<p>To treat hypertension as sole agent or to enhance the effects of another antihypertensive when given in combination. Also
         to treat edema associated with CHF, renal decompensation, and hepatic cirrhosis.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Anuria; hypersensitivity to thiazides, sulfonamides; pregnancy (category B), lactation.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>History of allergy; kidney and liver disease; gout; diabetes mellitus.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Edema</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 14 mg 12 times/d<br/><br/><span class="indicationtitle">Hypertension</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 24 mg/d in 12 divided doses<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 0.07 mg/kg/d in 12 divided doses<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give early in a.m. after breakfast to reduce gastric irritation and prevent interruption of sleep because of diuresis. If
            2 doses are ordered, schedule second dose no later than 3 p.m.
         </li>
<li>Store in tightly closed container at 15°30° C (59°86° F) unless otherwise instructed.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> Mood changes, unusual tiredness or weakness, dizziness, light-headedness, paresthesias. <span class="typehead">CV:</span> Irregular heartbeat, weak pulse, orthostatic hypotension, vasculitis.  <span class="typehead">GI:</span>  Dry mouth, increased thirst, nausea, vomiting, anorexia, diarrhea, pancreatitis, jaundice. <span class="typehead">Hematologic:</span>
<span class="speceff-life">Agranulocytosis</span>, thrombocytopenia, <span class="speceff-life">aplastic anemia</span>, leukopenia. <span class="typehead">Metabolic:</span>
<span class="speceff-common">Hyperglycemia,</span> glycosuria, <span class="speceff-common">hyperuricemia, hypokalemia,</span> exacerbation of gout, SLE.  <span class="typehead">Body as a Whole:</span> Hypersensitivity reactions, muscle spasm. <span class="typehead">Skin:</span> Photosensitivity. <span class="typehead">Special Senses:</span> Blurred vision, yellow vision (xanthopsia). 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<b>Amphotericin B,</b>
<span class="classification">corticosteroids</span> increase hypokalemic effects; may antagonize hypoglycemic effects of <span class="classification">sulfonylureas</span>, <b>insulin;</b>
<b>cholestyramine,</b>
<b>colestipol</b> decrease thiazide absorption; intensifies hypoglycemic and hypotensive effects of <b>diazoxide;</b> increased <b>potassium</b> and <b>magnesium</b> loss with <b>digoxin</b>may cause <b>digoxin</b> toxicity; decreases <b>lithium</b> excretion, thus increasing its toxicity; <span class="classification">nsaid</span>s may attenuate diuresisrisk of <span class="classification">nsaid</span>-induced kidney failure increased. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Onset:</span> 2 h. <span class="typehead">Peak:</span> 6 h. <span class="typehead">Duration:</span> 24 h. <span class="typehead">Distribution:</span> Crosses placenta; distributed into breast milk. <span class="typehead">Elimination:</span> Excreted in urine. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor BP and I&amp;O ratio during first phase of antihypertensive therapy. Report a sudden fall in BP, which may initiate severe
            postural hypotension and potentially dangerous perfusion problems, especially in the extremities.
         </li>
<li>
            							Note: Antihypertensive effects may be noted in 34 d; maximal effects may require 34 wk.
            						
         </li>
<li>Monitor older adult patients closely; they may be more sensitive to average adult dose.</li>
<li>Lab tests: Periodic serum electrolytes, blood glucose, CBC with differential, and platelet count.</li>
<li>Monitor patient for S&amp;S of hypokalemia (see Appendix F) and report promptly. Hypokalemia is rarely severe in most patients
            even on long-term therapy, but older adults are especially susceptible.
         </li>
<li>Monitor diabetics for loss of glycemic control or early signs of hyperglycemia (e.g., drowsiness, polyuria, anorexia, polydipsia).</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Eat a balanced diet (usually includes potassium-rich foods such as fruits and fruit juices) to prevent onset of hypokalemia.</li>
<li>Avoid OTC drugs unless approved by the physician. Many preparations contain both potassium and sodium and misused can induce
            electrolyte imbalance adverse effects.
         </li>
<li>Maintain prescribed dosage regimen, do not skip, reduce, or double doses or change dose intervals.</li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>